Statistical differentiation between direct and indirect effects of neuroleptics on negative symptoms

European Archives of Psychiatry and Clinical Neuroscience

Volumn 247, Issue 1, 1997, Pages 1-5

  Moller H J ^a   Muller H ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Negative symptoms; Neuroleptics; Path analysis; Risperidone; Schizophrenia

Indexed keywords

HALOPERIDOL; NEUROLEPTIC AGENT; RISPERIDONE;

ARTICLE; DEPRESSION; EXTRAPYRAMIDAL SYMPTOM; HUMAN; NEGATIVE SYNDROME; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 0031048052     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02916246     Document Type: Article

References (8)

1. Carpenter WT Jr, Heinrichs DW, Alphs LD (1985) Treatment of negative symptoms. Schizophr Bull 11 (3): 440-452
2. Chouinard G, Ross-Chouinard A, Annable L, Jones BG (1980) The Extrapyramidal Symptom Rating Scale (ESRS). Can J Neurol Sci 7: 233
3. Jöreskog K, Sörbom D (1988) LISREL 7. SPSS Inc, Chicago, III
4. Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13 (2): 261-276
5. Marder SR, Meibach RC (1994) Risperidone in the treatment of schizophrenia. Am J Psychiatry 13: 25-40
6. Möller H-J (1993) Neuroleptic treatment of negative symptoms in schizophrenic patients. Efficacy problems and methodological difficulties. Eur Neuropsychopharmacol 3: 1-11
7. Möller H-J, Müller H, Chouinard G, Borison RL, Schooler NR (1995) A path-analytical approach to differentiate between direct and indirect drug effects on negative symptoms in schizophrenic patients. A re-evaluation of the North American risperidone study. Eur Arch Psychiatry Clin Neurosci 245: 45-49
8. Müller H, Möller H-J (1994) Methodische Probleme bei der Analyse von Neuroleptikaeffekten auf Negativsymptomatik. In: Möller H-J, Laux G (eds) Fortschritte in der Diagnostik und Therapie schizophrener Minussymptomatik. Springer, Berlin Heidelberg New York, pp 63-77